4559:TYO
Zeria Pharmaceutical Co Ltd
1 925,00 JP¥
arrow_downward
-0,21%(-4,00) 1D
9 հոկ, 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
1 923 JP¥
High
1 940 JP¥
Low
1 919 JP¥
Mkt. cap
96,48 մլրդ
Avg. vol.
170,22 հզր
Volume
77,50 հզր
Dividend
2,55%
Quarterly dividend
12 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
10,31
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 մլն
No. of employees
2 հզր
Open
1 923 JP¥
High
1 940 JP¥
Low
1 919 JP¥
Mkt. cap
96,48 մլրդ
Avg. vol.
170,22 հզր
Volume
77,50 հզր
Dividend
2,55%
Quarterly dividend
12 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
10,31
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Simply Wall Street
·
5 րոպե առաջ
SolarEdge Technologies (SEDG) Appoints Gokul Krishnan To Lead North America Growth
Simply Wall Street
·
5 րոպե առաջ
Does Board AI Hire Change The Bull Case For Roper Technologies (ROP)?
Simply Wall Street
·
5 րոպե առաջ
Lineage (LINE) Following Its BSF Extension And The Undervalued Narrative
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd